Home › Compare › CMAXW vs ARCC

CMAXW vs ARCC: Dividend Comparison 2026

CMAXW yields 20833.33% · ARCC yields 9.06%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 CMAXW wins by $78708720625850728448.00M in total portfolio value
10 years
CMAXW
CMAXW
● Live price
20833.33%
Share price
$0.01
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$78708720625850728448.00M
Annual income
$77,972,479,019,762,930,000,000,000.00
Full CMAXW calculator →
ARCC
Ares Capital Corporation
● Live price
9.06%
Share price
$21.20
Annual div
$1.92
5Y div CAGR
3.1%
Payout ratio
88%
After 10 yrs · $10,000 · DRIP
Portfolio value
$43.8K
Annual income
$2,279.31
Full ARCC calculator →

Portfolio growth — CMAXW vs ARCC

📍 CMAXW pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodCMAXWARCC
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, CMAXW + ARCC cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
CMAXW pays
ARCC pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CMAXW
Annual income on $10K today (after 15% tax)
$1,770,833.33/yr
After 10yr DRIP, annual income (after tax)
$66,276,607,166,798,485,000,000,000.00/yr
ARCC
Annual income on $10K today (after 15% tax)
$769.81/yr
After 10yr DRIP, annual income (after tax)
$1,937.41/yr
At 15% tax rate, CMAXW beats the other by $66,276,607,166,798,485,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CMAXW + ARCC for your $10,000?

CMAXW: 50%ARCC: 50%
100% ARCC50/50100% CMAXW
Portfolio after 10yr
$39354360312925364224.00M
Annual income
$38,986,239,509,881,460,000,000,000.00/yr
Blended yield
99.06%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on ARCC right now

CMAXW
No analyst data
Altman Z
-7.4
Piotroski
3/9
ARCC
Analyst Ratings
24
Buy
7
Hold
Consensus: Buy
Price Target
$21.88
+3.2% upside vs current
Range: $21.00 — $23.00
Altman Z
0.8
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CMAXW buys
0
ARCC buys
0
No recent congressional trades found for CMAXW or ARCC in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricCMAXWARCC
Forward yield20833.33% ✓9.06%
Annual dividend / share$2.00 ✓$1.92
Payout ratio50% ✓88%
1-year div growth0%2% ✓
5-year div CAGR0%3.1% ✓
Portfolio after 10y$78708720625850728448.00M ✓$43.8K
Annual income after 10y$77,972,479,019,762,930,000,000,000.00 ✓$2,279.31
Total dividends collected$78660158496375930880.00M ✓$15.5K
Payment frequencyquarterlyquarterly
SectorStockBDC

Year-by-year: CMAXW vs ARCC ($10,000, DRIP)

YearCMAXW PortfolioCMAXW Income/yrARCC PortfolioARCC Income/yrGap
1← crossover$2,094,033$2,083,333.33$11,774$933.74+$2.08M → CMAXW
2$409,957,386$407,716,770.51$13,808$1,045.61+$409.94M → CMAXW
3$75,037,124,826$74,598,470,422.36$16,135$1,166.34+$75037.11M → CMAXW
4$12,841,257,574,210$12,760,967,850,647.00$18,786$1,296.19+$12841257.56M → CMAXW
5$2,054,684,712,278,176$2,040,944,566,673,771.00$21,800$1,435.41+$2054684712.26M → CMAXW
6$307,398,888,277,703,700$305,200,375,635,566,000.00$25,215$1,584.23+$307398888277.68M → CMAXW
7$43,002,429,063,308,950,000$42,673,512,252,851,814,000.00$29,076$1,742.84+$43002429063308.92M → CMAXW
8$5,625,127,515,678,174,000,000$5,579,114,916,580,434,000,000.00$33,430$1,911.44+$5625127515678174.00M → CMAXW
9$688,076,267,371,778,200,000,000$682,057,380,930,002,500,000,000.00$38,328$2,090.21+$688076267371778176.00M → CMAXW
10$78,708,720,625,850,720,000,000,000$77,972,479,019,762,930,000,000,000.00$43,827$2,279.31+$78708720625850728448.00M → CMAXW

CMAXW vs ARCC: Complete Analysis 2026

CMAXW — Stock

CareMax, Inc. provides chronic disease management services through physicians and health care professionals. It offers a suite of health care and social services to its patients, including primary care, specialty care, telemedicine, health and wellness, optometry, dental, pharmacy, and transportation; and services to children and adults through Medicaid programs, as well as through commercial insurance plans. The company also provides CareOptimize, a proprietary software and services platform that provides data, analytics, and rules-based decision tools/workflows for physicians in the United States. It operates multi-specialty medical care centers in Florida, Tennessee, Texas, and New York. The company is headquartered in Miami, Florida.

Full CMAXW Calculator →

ARCC — BDC

Ares Capital is the largest Business Development Company by assets. It provides financing to middle market companies and pays a generous quarterly dividend plus occasional special dividends. With $21B+ in AUM and diversified exposure across industries, ARCC is the benchmark BDC for income investors.

Full ARCC Calculator →
📬

Get this CMAXW vs ARCC comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CMAXW vs SCHDCMAXW vs JEPICMAXW vs OCMAXW vs KOCMAXW vs MAINCMAXW vs HTGCCMAXW vs GBDCCMAXW vs ORCC

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.